Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lifecore Biomedical Inc.

    NASDAQ: LFCR · Real-Time Price · USD
    6.67
    -0.06 (-0.89%)
    At close: Jun 16, 2025, 3:59 PM
    6.67
    0.08%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    Lifecore Biomedical Statistics

    Share Statistics

    Lifecore Biomedical has 37.03M shares outstanding. The number of shares has increased by 21.21% in one year.

    Shares Outstanding

    n/a
    		 37.03M

    Shares Change (YoY)

    n/a
    		 21.21%

    Shares Change (QoQ)

    n/a
    		 0.54%

    Owned by Institutions (%)

    n/a
    		 72.23%

    Shares Floating

    n/a
    		 32.67M

    Failed to Deliver (FTD) Shares

    n/a
    		 871

    FTD / Avg. Volume

    n/a
    		 0.33%

    Short Selling Information

    The latest short interest is 2.32M, so 6.27% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.32M

    Short % of Shares Out

    n/a
    		 6.27%

    Short % of Float

    n/a
    		 10.15%

    Short Ratio (days to cover)

    n/a
    		 6.56

    Valuation Ratios

    The PE ratio is 14.26 and the forward PE ratio is -9.61. Lifecore Biomedical's PEG ratio is -0.13.

    PE Ratio

    n/a
    		 14.26

    Forward PE

    n/a
    		 -9.61

    PS Ratio

    n/a
    		 1.34

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 3.18

    P/FCF Ratio

    n/a
    		 -9.44

    PEG Ratio

    n/a
    		 -0.13
    Financial Ratio History

    Enterprise Valuation

    Lifecore Biomedical has an Enterprise Value (EV) of 293.16M.

    EV / Sales

    n/a
    		 2.29

    EV / EBITDA

    n/a
    		 8.23

    EV / EBIT

    n/a
    		 -1350.98

    EV / FCF

    n/a
    		 -16.16

    Financial Position

    The company has a current ratio of 2.08, with a Debt / Equity ratio of 2.42.

    Current Ratio

    n/a
    		 2.08

    Quick Ratio

    n/a
    		 1.06

    Debt / Equity

    n/a
    		 2.42

    Debt / EBITDA

    n/a
    		 3.66

    Debt / FCF

    n/a
    		 -7.19

    Interest Coverage

    n/a
    		 -0.49

    Financial Efficiency

    Return on Equity is 22.29% and Return on Invested Capital is -3.94%.

    Return on Equity

    n/a
    		 22.29%

    Return on Assets

    n/a
    		 4.39%

    Return on Invested Capital

    n/a
    		 -3.94%

    Revenue Per Employee

    n/a
    		 $244,772.9

    Profits Per Employee

    n/a
    		 $22,925.57

    Employee Count

    n/a
    		 524

    Asset Turnover

    n/a
    		 0.47

    Inventory Turnover

    n/a
    		 2.16

    Taxes

    Income Tax

    n/a
    		 183K

    Effective Tax Rate

    n/a
    		 1.92%

    Stock Price Statistics

    The stock price has increased by 29.51% in the last 52 weeks. The beta is 0.67, so Lifecore Biomedical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.67

    52-Week Price Change

    n/a
    		 29.51%

    50-Day Moving Average

    n/a
    		 6.56

    200-Day Moving Average

    n/a
    		 6.2

    Relative Strength Index (RSI)

    n/a
    		 47.01

    Average Volume (20 Days)

    n/a
    		 267,104

    Income Statement

    In the last 12 months, Lifecore Biomedical had revenue of 128.26M and earned 12.01M in profits. Earnings per share was 0.39.

    Revenue

    n/a
    		 128.26M

    Gross Profit

    n/a
    		 41.85M

    Operating Income

    n/a
    		 -8.84M

    Net Income

    n/a
    		 12.01M

    EBITDA

    n/a
    		 35.6M

    EBIT

    n/a
    		 27.6M

    Earnings Per Share (EPS)

    n/a
    		 0.39
    Full Income Statement

    Balance Sheet

    The company has 8.46M in cash and 130.36M in debt, giving a net cash position of -121.9M.

    Cash & Cash Equivalents

    n/a
    		 8.46M

    Total Debt

    n/a
    		 130.36M

    Net Cash

    n/a
    		 -121.9M

    Retained Earnings

    n/a
    		 -166.52M

    Total Assets

    n/a
    		 237.69M

    Working Capital

    n/a
    		 53.09M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -217K and capital expenditures -17.92M, giving a free cash flow of -18.14M.

    Operating Cash Flow

    n/a
    		 -217K

    Capital Expenditures

    n/a
    		 -17.92M

    Free Cash Flow

    n/a
    		 -18.14M

    FCF Per Share

    n/a
    		 -0.6
    Full Cash Flow Statement

    Margins

    Gross margin is 32.63%, with operating and profit margins of -6.9% and 9.37%.

    Gross Margin

    n/a
    		 32.63%

    Operating Margin

    n/a
    		 -6.9%

    Pretax Margin

    n/a
    		 7.42%

    Profit Margin

    n/a
    		 9.37%

    EBITDA Margin

    n/a
    		 27.76%

    EBIT Margin

    n/a
    		 -6.9%

    FCF Margin

    n/a
    		 -14.14%

    Dividends & Yields

    LFCR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 7.01%

    FCF Yield

    n/a
    		 -10.59%
    Dividend Details

    Analyst Forecast

    The average price target for LFCR is $8, which is 19.9% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 19.9%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 3.96

    Graham Upside

    n/a
    		 -40.63%

    Scores

    Altman Z-Score

    n/a
    		 0

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist